l-697661 has been researched along with efavirenz in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corbett, JW; Cordova, BC; Erickson-Viitanen, SK; Klabe, RM; Kresge, KJ; Pan, S; Rodgers, JD | 1 |
Dornadula, G; Grobler, JA; Hazuda, DJ; Miller, MD; Rice, MR; Simcoe, AL | 1 |
2 other study(ies) available for l-697661 and efavirenz
Article | Year |
---|---|
Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase.
Topics: Anti-HIV Agents; Combinatorial Chemistry Techniques; Cytopathogenic Effect, Viral; Enzyme Inhibitors; Fluorine; HIV Reverse Transcriptase; HIV-1; Inhibitory Concentration 50; Mutation; Pyridones; Structure-Activity Relationship | 2001 |
HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitro.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Benzoxazoles; Cyclopropanes; DNA; Dose-Response Relationship, Drug; Drug Resistance, Viral; Enzyme Inhibitors; HIV Reverse Transcriptase; In Vitro Techniques; Inhibitory Concentration 50; Ligands; Models, Genetic; Oxazines; Pyridones; Reverse Transcriptase Inhibitors; Stochastic Processes; Transcription, Genetic; Virus Replication | 2007 |